Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News > 2022

Pharma News, 2022

FDA Withdraws Umbralisib Due to Elevated Mortality Risk
FDA Withdraws Umbralisib Due to Elevated Mortality Risk
The FDA announced that it has withdrawn approval for umbralisib (Ukoniq, TG Therapeutics), based on an updated analysis of the phase 3 UNITY-CLL clinical trial, which continues to show “a possibl...
Study Supports Paxlovid’s Efficacy Against COVID-19 and Omicron Variant
Study Supports Paxlovid’s Efficacy Against COVID-19 and Omicron Variant

Pfizer’s Paxlovid (nirmatrelvir, ritonavir) significantly reduced the risk of severe COVID-19 infection or mortality, Israeli researchers reported.

FDA Approves First Measles Vaccine in Half a Century
FDA Approves First Measles Vaccine in Half a Century
GSK shared exciting news Monday morning, announcing that the company’s vaccine for protection against measles, mumps and rubella (MMR) has been approved by the U.S. Food and Drug Administration.&...
BMS Picks up High Potential NSCLC Drug in $4.1B Turning Point Acquisition
BMS Picks up High Potential NSCLC Drug in $4.1B Turning Point Acquisition

Bristol Myers Squibb announced Friday that it is acquiring San Diego-based Turning Point Therapeutics in a deal totaling about $4.1 billion.

Roche, Repare Ink $1.2B Deal for Development of Cancer Therapy
Roche, Repare Ink $1.2B Deal for Development of Cancer Therapy
Shares of Repare Therapeutics are soaring more than 27% in premarket trading following the announcement Wednesday of a global cancer collaboration valued at up to $1.2 billion with Swiss pharma gi...
FDA grants Fast Track Designation to mocravimod with HSCT for acute myeloid leukemia
FDA grants Fast Track Designation to mocravimod with HSCT for acute myeloid leukemia
The FDA granted fast track designation to mocravimod in combination with allogeneic hematopoietic stem cell transplantation for post-remission therapy of acute myeloid leukemia. ...
US FDA grants fast track designation to Midatech Pharma’s MTX110 to treat recurrent glioblastoma
US FDA grants fast track designation to Midatech Pharma’s MTX110 to treat recurrent glioblastoma
Midatech Pharma PLC, an R&D biotechnology company, announced that upon submitting an application to the US Food and Drug Administration (FDA), its development programme of MTX110 for the treatm...
NICE Recommends UCB’s Fintepla for Dravet Syndrome-Related Seizures
NICE Recommends UCB’s Fintepla for Dravet Syndrome-Related Seizures
The UK’s National Institute for Healthcare Excellence (NICE) has recommended UCB’s Fintepla (fenfluramine) for National Health Service (NHS) use in patients with Dravet syndrome-associated seiz...
Chemical inhibitor blocks final path to cell death in mice with Parkinson's symptoms
Chemical inhibitor blocks final path to cell death in mice with Parkinson's symptoms
In studies in mice, Johns Hopkins Medicine researchers say they have identified a chemical compound that stops the final events in the pathway linked to the death of brain cells in Parkinson's dise...
Astellas’ subsidiary, Xyphos & GO Therapeutics ink research and license agreement to develop novel antibodies for immuno-oncology
Astellas’ subsidiary, Xyphos & GO Therapeutics ink research and license agreement to develop novel antibodies for immuno-oncology
Astellas Pharma Inc. and GO Therapeutics, Inc. announced that Xyphos Biosciences, Inc., (a wholly owned subsidiary of Astellas, Xyphos) and GO have entered into a strategic research collaboration a...
WHO says monkeypox has been spreading undetected as global cases rise to more than 550
WHO says monkeypox has been spreading undetected as global cases rise to more than 550

The World Health Organization on Wednesday confirmed more than 550 monkeypox cases across 30 countries as the virus continues to spread across the globe.

FDA Pulls Approval for TG Therapeutics' Cancer Drug
FDA Pulls Approval for TG Therapeutics' Cancer Drug
Shares of TG Therapeutics are falling fast in Wednesday trading after the U.S. Food and Drug Administration announced it was pulling approval of the cancer drug Ukoniq (umbralisib).
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand